Medicine and Dentistry
Tumor Treating Fields
100%
Surgery
100%
Skull
100%
Glioblastoma
100%
Combination Therapy
80%
Patient
79%
Recurrent Disease
55%
Brain
50%
Adult
50%
Organ
50%
Phase I Trials
50%
Overall Survival
31%
Adverse Event
26%
Neoplasm
26%
Brainstem
25%
Spinal Cord
25%
Radiation Therapy
25%
Brain Tumor
25%
Neuro-Oncology
25%
Toxicity
20%
Malignant Neoplasm
18%
Progression Free Survival
16%
Therapeutic Procedure
15%
Physician
15%
Arm
15%
Pituitary Gland
12%
Hippocampus
12%
Optic Nerve
12%
Magnetic Resonance Imaging
12%
Gadolinium
12%
Consensus
12%
Skull Defect
11%
Bevacizumab
11%
Survival Rate
11%
Cancer Therapy
10%
Combined Therapy
10%
Follow up
10%
Temozolomide
5%
Irinotecan
5%
Treatment Duration
5%
Exanthem
5%
Shunting
5%
Skin
5%
Quality of Life
5%
Steroid
5%
Karnofsky Performance Status
5%
Cancer Surgery
5%
Age
5%
Consent
5%
Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Neoplasm
100%
Recurrent Disease
55%
Overall Survival
31%
Adverse Event
26%
Toxicity
20%
Progression Free Survival
16%
Bevacizumab
11%
Survival Rate
11%
Study Design
10%
Malignant Neoplasm
5%
Irinotecan
5%
Temozolomide
5%
Rash
5%
Preclinical Study
5%
Morbidity
5%
Steroids
5%